LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 658 | 741 | 3846 | 0.1927 | 0.0260 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 658 | 860 | 3846 | 0.2237 | 0.0634 |
Hs 578T | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 658 | 3667 | 3846 | 0.9536 | 0.9440 |
Hs 578T | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 658 | 436 | 3846 | 0.1135 | -0.0696 |
Hs 578T | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3296 | 3846 | 0.8570 | 0.8274 |
Hs 578T | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 658 | 503 | 3846 | 0.1309 | -0.0486 |
Hs 578T | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 658 | 645 | 3846 | 0.1677 | -0.0041 |
Hs 578T | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 658 | 3141 | 3846 | 0.8167 | 0.7788 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3729 | 3846 | 0.9697 | 0.9635 |
Hs 578T | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 658 | 494 | 3846 | 0.1284 | -0.0515 |
Hs 578T | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 658 | 1400 | 3846 | 0.3642 | 0.2329 |
Hs 578T | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3908 | 3846 | 1.0162 | 1.0195 |
Hs 578T | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 658 | 183 | 3846 | 0.0476 | -0.1491 |
Hs 578T | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3493 | 3846 | 0.9084 | 0.8894 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3644 | 3846 | 0.9475 | 0.9366 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 658 | 154 | 3846 | 0.0401 | -0.1581 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 658 | 147 | 3846 | 0.0384 | -0.1601 |
Hs 578T | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 658 | 2496 | 3846 | 0.6490 | 0.5765 |
Hs 578T | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 658 | 3846 | 0.1713 | 0.0002 |
Hs 578T | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3771 | 3846 | 0.9805 | 0.9764 |
Hs 578T | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 658 | 1722 | 3846 | 0.4478 | 0.3338 |
Hs 578T | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 658 | 2328 | 3846 | 0.6055 | 0.5240 |
Hs 578T | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 658 | 945 | 3846 | 0.2459 | 0.0902 |
Hs 578T | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 658 | 832 | 3846 | 0.2164 | 0.0546 |
Hs 578T | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 658 | 1572 | 3846 | 0.4087 | 0.2867 |